2025 Updated Guidelines of Care for the Management of Atopic Dermatitis in Adults

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/66/77/29/667729bb-b72a-4abb-8a66-d0f293806148/mza_16977989797155034764.jpg/600x600bb.jpg

Skinfluenced - The Skin Podcast

15 episodes

1 week ago

🧴 Harnessing the power of technology, Skinfluenced: The Skin Podcast keeps you plugged into the fast-moving worlds of dermatology, wellness, and aesthetics. From the latest journal articles and groundbreaking studies, to new FDA approvals, new product launches, and clinical insights—this podcast is your go-to source for evidence-based updates that matter. Whether you're a seasoned provider or just dipping your toe in the sand, you'll stay one step ahead of the trends, the science, and your skin. Disclaimer: All content is for educational purposes only and does not constitute medical advice.

Medicine

Health & Fitness

RSS

All content for Skinfluenced - The Skin Podcast is the property of Skinfluenced - The Skin Podcast and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/44144955/44144955-1757795946265-3a4ba780d1888.jpg

2025 Updated Guidelines of Care for the Management of Atopic Dermatitis in Adults

Skinfluenced - The Skin Podcast

17 minutes 6 seconds

2 months ago

2025 Updated Guidelines of Care for the Management of Atopic Dermatitis in Adults

Disclaimer: This podcast is not sponsored by or associated with any of the products mentioned in today's episode.

In this episode of Skinfluenced: The Skin Podcast, we’re breaking down the American Academy of Dermatology’s June 2025 focused update on the management of Atopic Dermatitis (AD) in adults.

We’ll highlight how to integrate the latest high-quality evidence into practice, including new FDA-approved therapies that are reshaping the treatment landscape. From tapinarof and roflumilast creams, to biologics like lebrikizumab and nemolizumab, we review the data behind their efficacy and safety, drawn from multiple randomized controlled trials.

You’ll also learn how these treatments fit within current regimens—whether used alone or in combination—so you can deliver the most accurate, evidence-based care for your AD patients.
#AtopicDermatitis #Eczema #ADGuidelines #AADGuidelines #Dermatology #SkinHealth #NewTreatments #FDAApproved #TopicalTherapies #SystemicTherapies #Lebrikizumab #Nemolizumab #Tapinarof #Roflumilast #Biologics #ClinicalGuidelines #EvidenceBasedMedicine #AADUpdate2025 #AdultAD #ADManagement #DermUpdate #SkinScience #Dermatology #DermatologyProvider #Dermatologist #CosmeticDermatology #Aesthetics #PhysicianAssistant #PhysicianAssociate #NursePractitioner #SkinfluencedPodcast #DermatologyPodcast

Link to Source(s):

Focused Update: Guidelines of Care for the Management of Atopic Dermatitis in Adults. Davis, Dawn M.R. et al. Journal of the American Academy of Dermatology, Volume 93, Issue 3, 745.e1 - 745.e7 https://www.jaad.org/article/S0190-9622(25)02125-5/fulltext